Oversold

BDX

Same as last week
Valuation16/ 100
Cash flow & growth44/ 100
Upside potential29/ 100
Risk potential27/ 100

BDX's valuation is expensive, fundamentals are below averages and the outlook sends mixed signals, though analyst coverage is limited.

Valuation

Historical cheapness: current PE is 53.6× versus the full-history median of 27.5× shown in the valuation table, producing 15.3/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 15.8/100. The model applies a 12.7% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 27.1× (18-month half-life). The favorable scenario uses 48.5× PE and $4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue -2.6%, earnings -40.3%, operating margin -1.9 percentage points. Free cash flow is 12.5% of revenue. The business score is 43.8/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $4.04 of EPS and a 48.5× PE, suggesting about $195.92 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $204.53. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $2.82 of EPS and a 46.4× PE, suggesting a share price of about $130.77 — 27% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

BDX vs Historical averages

MetricCurrentAverageRelative
PE54x32x68% higher
PE percentile875074% higher
EPS$3.32$5.3137% lower
FCF$2.6B$2.6B1% lower
Loading historical comparisons…

BDX’s earnings and cash flow are below their historical averages, while its earnings multiple is higher.

BDX Forward outlook

MetricOutlook
Forward valuationStable
Forward earningsStable
Forward revenueDecline
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionTight

BDX’s outlook is mixed, with declining sales expectations a concern.

BDX PE Valuation

Loading pe valuation table…

This table applies BDX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

BDX Earnings Per Share

Loading earnings per share…

This chart tracks BDX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

BDX Quarterly Revenue

Loading quarterly revenue…

This chart tracks BDX's quarterly revenue over time and shows how sales are changing from year to year.

BDX Free Cash Flow

Loading free cash flow…

This chart tracks BDX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

BDX Total Shares

Loading shares over time…

This chart tracks changes in BDX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

BDX Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

BDX PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares BDX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

BDX Weekly Price

Loading weekly price…

This chart uses BDX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

BDX Weekly Moving Averages

Loading weekly moving averages…

This chart compares BDX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

BDX Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

UNH

Same as last week
Valuation47/ 100
Cash flow & growth46/ 100
Upside potential49/ 100
Risk potential31/ 100

UNH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.

Valuation

Historical cheapness: current PE is 24.4× versus the full-history median of 21.5× shown in the valuation table, producing 41.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 46.9/100. The model applies a 21.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 22.4× (18-month half-life). The favorable scenario uses 24.6× PE and $20.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +6.5%, earnings -32.6%, operating margin -2.5 percentage points. Free cash flow is 5.2% of revenue. The business score is 45.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $20.39 of EPS and a 24.6× PE, suggesting a share price of about $500.50. Valuation history and outlook inform the PE.

The displayed favorable scenario is 32% upside, or about $500.40.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $13.45 of EPS and a 19.6× PE, suggesting a share price of about $262.95 — 31% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

UNH vs Historical averages

MetricCurrentAverageRelative
PE24x23x8% higher
PE percentile715042% higher
EPS$15.55$18.6717% lower
FCF$23.6B$21.7B9% higher
Loading historical comparisons…

UNH’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.

UNH Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStable
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionModerate

UNH’s outlook is generally improving, with growth expectations supporting the valuation case.

UNH PE Valuation

Loading pe valuation table…

This table applies UNH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

UNH Earnings Per Share

Loading earnings per share…

This chart tracks UNH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

UNH Quarterly Revenue

Loading quarterly revenue…

This chart tracks UNH's quarterly revenue over time and shows how sales are changing from year to year.

UNH Free Cash Flow

Loading free cash flow…

This chart tracks UNH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

UNH Total Shares

Loading shares over time…

This chart tracks changes in UNH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

UNH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

UNH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares UNH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

UNH Weekly Price

Loading weekly price…

This chart uses UNH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

UNH Weekly Moving Averages

Loading weekly moving averages…

This chart compares UNH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

UNH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.